CY1112161T1 - STABLE CRYSTAL CALCULATE AFTER CALCIUM SALT TOY 5-METHYLO- (6S) - tetrahydrofolic acid - Google Patents

STABLE CRYSTAL CALCULATE AFTER CALCIUM SALT TOY 5-METHYLO- (6S) - tetrahydrofolic acid

Info

Publication number
CY1112161T1
CY1112161T1 CY20111101182T CY111101182T CY1112161T1 CY 1112161 T1 CY1112161 T1 CY 1112161T1 CY 20111101182 T CY20111101182 T CY 20111101182T CY 111101182 T CY111101182 T CY 111101182T CY 1112161 T1 CY1112161 T1 CY 1112161T1
Authority
CY
Cyprus
Prior art keywords
methylo
toy
tetrahydrofolic acid
calcium salt
stable crystal
Prior art date
Application number
CY20111101182T
Other languages
Greek (el)
Inventor
HANS RUDOLF MüLLER
Thomas Egger
Rudolf Moser
Original Assignee
Merck & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09178428A external-priority patent/EP2192120B1/en
Application filed by Merck & Cie filed Critical Merck & Cie
Publication of CY1112161T1 publication Critical patent/CY1112161T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η εφεύρεση αναφέρεται σε σταθερό κρυσταλλικό μετά ασβεστίου άλας του 5-μεθυλο-(6S)-τετραϋδροφολικού οξέος, σε μέθοδο για την παραγωγή αυτού του άλατος καθώς και στη χρήση αυτού ως συστατικό για την παραγωγή φαρμακευτικών μέσων, ως συμπλήρωμα διατροφής και σε παρασκευάσματα που περιέχουν αυτό το άλας.The invention relates to a fixed calcium crystalline salt of 5-methyl- (6S) -tetrahydrofolic acid, to a method for the production of this salt and to its use as an ingredient in the manufacture of pharmaceuticals, as a food supplement and in preparations containing this salt.

CY20111101182T 1999-04-15 2011-11-30 STABLE CRYSTAL CALCULATE AFTER CALCIUM SALT TOY 5-METHYLO- (6S) - tetrahydrofolic acid CY1112161T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6951999 1999-04-15
EP09178428A EP2192120B1 (en) 1999-04-15 2000-04-08 Stable crystalline calcium salt of 5-methyl-(6S)-tetrahydrofolic acid

Publications (1)

Publication Number Publication Date
CY1112161T1 true CY1112161T1 (en) 2015-12-09

Family

ID=44898336

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20111101182T CY1112161T1 (en) 1999-04-15 2011-11-30 STABLE CRYSTAL CALCULATE AFTER CALCIUM SALT TOY 5-METHYLO- (6S) - tetrahydrofolic acid
CY20111101181T CY1112133T1 (en) 1999-04-15 2011-11-30 STABLE CRYSTAL CALCULATE AFTER CALCIUM SALT TOY 5-METHYLO- (6S) -TETRAHODOLIC ACID

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20111101181T CY1112133T1 (en) 1999-04-15 2011-11-30 STABLE CRYSTAL CALCULATE AFTER CALCIUM SALT TOY 5-METHYLO- (6S) -TETRAHODOLIC ACID

Country Status (2)

Country Link
AT (2) ATE530551T1 (en)
CY (2) CY1112161T1 (en)

Also Published As

Publication number Publication date
CY1112133T1 (en) 2015-11-04
ATE530550T1 (en) 2011-11-15
ATE530551T1 (en) 2011-11-15

Similar Documents

Publication Publication Date Title
CY1111313T1 (en) 5-Methyl-(6S) -tetrahydrofolic acid crystalline fixed salt
YU2003A (en) Stable salts of o-acetylsalicyclic acid with basic amino acids
HUP0300731A2 (en) Valsartan salts, process for their preparation and pharmaceutical compositions thereof
TNSN01108A1 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
DE60025328D1 (en) METHOD FOR THE PRODUCTION OF MULTIPLE NETWORKED HYALURONIC ACID DERIVATIVES
BRPI0417043A (en) pharmaceutical composition, solid dosage form, manufacturing method of solid dosage form, and, use of the composition
ATE300189T1 (en) PRODUCTION OF HIGHLY SOLUBLE AND STABLE MINERAL SUPPLEMENTS
CY1107681T1 (en) USE OF PRODUCERS THROUGHOUT TO PRODUCE MEDICINES
EP1373207A4 (en) Novel amlodipine camsylate and method for preparing thereof
AU2689292A (en) Cyclohexaneacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
NO964699L (en) Stable crystalline tetrahydrofolic acid salts and processes for their preparation
CY1107349T1 (en) ALPHA-KETOGLUAR ACTIVE INGREDIENTS AND CONTAINERS THAT CONTAIN IT
CY1105019T1 (en) SUBSTITUTED C-IMIDAZO-[1,2-A]PYRIDIN-3-YL-METHYLAMINES
WO2003047567A8 (en) STABLE, ACID, AQUEOUS SOLUTION CONTAINING α-LIPONIC ACID (DERIVATIVES), METHOD FOR THE PRODUCTION THEREOF AND USE OF THE SAME
CY1112133T1 (en) STABLE CRYSTAL CALCULATE AFTER CALCIUM SALT TOY 5-METHYLO- (6S) -TETRAHODOLIC ACID
CY1109762T1 (en) NEW CRYSTAL FORM OF TOY 8-KYAN-1-CYCLOPPOPYL-7- (1S, 6S-2,8-DIAZADICYCYL [4.3.0] ENENAN-8-Yl) -6-Fluoro-1,4-Dihydro-4-Oxo- 3-Quinoline-carboxylic acid
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
YU74401A (en) Process of preparing 2s-3-amino-3-arylpropionic acid and derivatives thereof
UA85235C2 (en) Crystalline anhydrous aripiprazole d, method for production thereof, pharmaceutical composition containing crystalline anhydrous aripiprazole d, and method for production thereof
CY1115042T1 (en) Oxygenated esters of 4-iodophenylaminobenzohydroxamic acids
HRP20070062T3 (en) Erythropoietin solution formulation
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS
MXPA04002400A (en) Salicylic acid salts, methods for the production and use thereof as medicaments.
ATE236178T1 (en) CRYSTALLINE L-ASCORBIC ACID-2-PHOSPHORIC ACID POTASSIUM SALT AND METHOD FOR THE PRODUCTION THEREOF
ES2063784T3 (en) PROCEDURE FOR THE PREPARATION OF PIRROLIZINE DERIVATIVES.